Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

Vigabatrin for the Treatment of Cocaine Dependency

ClinicalTrials.gov ID: NCT01281202

Public ClinicalTrials.gov record NCT01281202. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study

Study identification

NCT ID
NCT01281202
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Catalyst Pharmaceuticals, Inc.
Industry
Enrollment
207 participants

Conditions and interventions

Interventions

  • Vigabatrin Drug
  • Matching Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2010
Primary completion
Sep 30, 2012
Completion
Nov 30, 2012
Last update posted
May 17, 2016

2011 – 2012

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Matrix Institute on Addictions Los Angeles California 90016
Friends Research Institute Torrance California 90502
VA Medical Center Denver Colorado 80220
University of Miami School of Medicine Miami Florida 33136
NeuroPsychiatric Research & Practice Assoc., Ltd. Oak Brook Illinois 60523
Mountain Manor Treatment Center @ Baltimore Baltimore Maryland 21229
Boston University School of Medicine Boston Massachusetts 02118
Pacific Institute for Research and Evaluation Albuquerque New Mexico 87102
Western Psychiatric Inst. and Clinic Pittsburgh Pennsylvania 15213
Medical University of South Carolina Charleston South Carolina 29403
Pillar Clinical Research, LLC Dallas Texas 75243
University of Texas Health Science Center at Houston Houston Texas 77054
George E Wahlen VA Medical Center Salt Lake City Utah 84148

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01281202, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 17, 2016 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01281202 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →